Abstract
Extract
A large number of related compounds, all based on the prototype parent compound thiabendazole are now available on the market, each one claiming distinct advantages and applications for anti-parasitic use. The ever increasing number of benzimidazoles appearing regularly is a good example of so called molecular manipulation of molecular roulette whereby individual pharmaceutical companies endeavour to compete with a rival company's successful product without breaching the patent rights of a particular compound.